Results 21 to 30 of about 6,751 (146)

Post-Treatment Lyme Disease Syndrome: Need for Diagnosis and Treatment. [PDF]

Cureus, 2021
With the continued surge in Lyme disease cases, post-treatment Lyme disease syndrome (PTLDS) is becoming a more pressing health concern. The aim of this review is to identify comprehensive treatment strategies for PTLDS patients. Unfortunately, universal guidelines for diagnosing and treating PTLDS do not currently exist.
Maksimyan S, Syed MS, Soti V.
europepmc   +4 more sources

Autonomic Symptoms in Post-Treatment Lyme Disease: Insights From the COMPASS-31 and the 10-Minute Active Stand Test [PDF]

Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Objective: To determine the prevalence of autonomic symptoms in post-treatment Lyme disease (PTLD) and identify clinical factors that associate with abnormal hemodynamics on the 10-minute active stand test.
Brittany L. Adler, MD, Alison W. Rebman, MPH, Tae Chung, MD, John B. Miller, MD, Marzieh Keshtkarjahromi, MD, MPH, Ting Yang, PhD, Chatuthanai Savigamin, MD, MSc, MPH, Alba Azola, MD, Peter C. Rowe, MD, John N. Aucott, MD   +9 more
doaj   +2 more sources

Cost of illness in patients with post-treatment Lyme disease syndrome in Belgium. [PDF]

Eur J Public Health, 2023
Abstract Background A proportion of patients with Lyme borreliosis (LB) report long-term persisting signs and symptoms, even after recommended antibiotic treatment, which is termed post-treatment Lyme disease syndrome (PTLDS).
Willems R, Verhaeghe N, Perronne C, Borgermans L, Annemans L.   +4 more
europepmc   +5 more sources

Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data. [PDF]

EBioMedicine, 2023
Post-treatment Lyme disease syndrome (PTLDS) is used to describe Lyme disease patients who have the infection cleared by antibiotic but then experienced persisting symptoms of pain, fatigue, or cognitive impairment. Currently, little is known about the cause or epidemiology of PTLDS.We conducted a data-driven study with a large nationwide ...
Chung MK, Caboni M, Strandwitz P, D'Onofrio A, Lewis K, Patel CJ.   +5 more
europepmc   +3 more sources

Reassessing Chronic Lyme Disease and Post-Treatment Lyme Disease Syndrome as Focal Infections. [PDF]

Cureus
Lakos A, Nagy G, Varga Z, Rásonyi-Kovács P, Hornok S.   +4 more
europepmc   +3 more sources

Lyme disease and the pursuit of a clinical cure

Frontiers in Medicine, 2023
Lyme disease, caused by the spirochete Borrelia burgdorferi, is the most common vector-borne illness in the United States. Many aspects of the disease are still topics of controversy within the scientific and medical communities.
Heather Adkison, Monica E. Embers
doaj   +1 more source

What Makes It Tick: Exploring the Mechanisms of Post-treatment Lyme Disease Syndrome. [PDF]

Cureus
Post-treatment Lyme disease syndrome (PTLDS), which may also be referred to incorrectly as "chronic Lyme disease," is defined by the Infectious Diseases Society of America (IDSA) as the presence of fatigue, pain, and/or cognitive complaints with the functional impact that persists for more than six months after completing treatment for Lyme disease (LD)
Wester KE, Nwokeabia BC, Hassan R, Dunphy T, Osondu M, Wonders C, Khaja M.   +6 more
europepmc   +3 more sources

Cognitive Decline in Post-treatment Lyme Disease Syndrome [PDF]

Archives of Clinical Neuropsychology, 2018
Patient-reported cognitive complaints are common in those with post-treatment Lyme disease syndrome (PTLDS). Objective evidence of cognitive impairment in this population is variable in part due to methodological variability in existing studies. In this study, we sought to use a systematic approach to characterizing PTLDS based on the most current ...
Pegah, Touradji, John N, Aucott, Ting, Yang, Alison W, Rebman, Kathleen T, Bechtold   +4 more
openaire   +2 more sources

Immune Responses to Some Viral Infections That Have a High Evolutionary Potential—A Case Report with Literature Review

Life, 2022
Viral infections are a key issue in modern medicine. SARS-CoV-2 infection confirms that we are not sufficiently prepared for these unforeseen infections. The COVID-19 pandemic has cultivated a great sense of fear and distrust in patients.
Maria Lucia Sur, Bogdan-Stefan Moldovan, Diana Mocanu, Gabriel Samasca, Iulia Lupan, Ionel Armat, Marin Harabagiu, Genel Sur, Calin Lazar   +8 more
doaj   +1 more source

Metabolic Response in Patients With Post-treatment Lyme Disease Symptoms/Syndrome [PDF]

Clinical Infectious Diseases, 2020
Abstract Background Post-treatment Lyme disease symptoms/syndrome (PTLDS) occurs in approximately 10% of patients with Lyme disease following antibiotic treatment. Biomarkers or specific clinical symptoms to identify patients with PTLDS do not currently exist and the PTLDS classification is based on ...
Bryna L Fitzgerald, Barbara Graham, Mark J Delorey, Adoracion Pegalajar-Jurado, M Nurul Islam, Gary P Wormser, John N Aucott, Alison W Rebman, Mark J Soloski, John T Belisle, Claudia R Molins   +10 more
openaire   +2 more sources